Egetis Therapeutics AB (PDPHF) Q2 2026 Earnings

29AprConfirmed
Q2 2026
-0.03
-0.02
-0.02
-0.02

Details

Expected EPS
-0.019988
Actual EPS
-0.025248
Surprise EPS
-0.01
Surprise Percent
+26.32%

Description

Egetis Therapeutics AB (PDPHF) has reported earnings of -0.025248 per share for Q2 2026.

0 Comments

Share your thoughts